ArticleCellular oncology (Dordrecht, Netherlands)2024

LILRB2 promotes immune escape in breast cancer cells via enhanced HLA-A degradation.

Zhiyuan Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.